Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif containing 60 pseudogene 19 (TRIM60P19) is a sequence in the human genome classified as a pseudogene, meaning it is a non-functional copy of the tripartite motif-containing 60 (TRIM60) gene. Pseudogenes do not encode functional proteins, but in some cases may produce noncoding RNAs with potential regulatory activity. There are no reports of TRIM60P19 being transcribed, functional, or involved as a therapeutic target, nor is it implicated in any disease as an actionable biomarker or drug target[1][3]. Pseudogenes in general can sometimes regulate their parent gene or related pathways via mechanisms such as RNA interference or acting as competitive endogenous RNAs, but this has not been demonstrated for TRIM60P19[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 60 pseudogene 19 (TRIM60P19).